UCLA Health ranked a top hospital for cancer care by U.S. News and World Report
UCLA Health and the UCLA Jonsson Comprehensive Cancer Center consistently recognized for patient care and research
Cancer care at UCLA Health through the Jonsson Comprehensive Cancer Center has been ranked the 13th best in the country by U.S. News & World Report. The publication’s annual ranking also named UCLA Health No. 1 in Los Angeles and California and No. 4 nationally as part of its overall 2020-2021 Best Hospitals Honor Roll. This prestigious distinction is awarded to only 20 U.S. hospitals each year. The hospitals on this list deliver the highest quality of care across a range of specialties, procedures and conditions, including cancer care.
Along with the UCLA Jonsson Comprehensive Cancer Center, UCLA Health is consistently recognized for excellence in patient care, research and education.
“We are pleased to place amongst the top hospitals for treating cancer,” said Michael Teitell, MD, PhD, director of the Jonsson Comprehensive Cancer Center at UCLA. “UCLA physicians and staff are dedicated to providing the best possible care for people battling cancer. Our researchers also focus on developing innovative therapies, technologies, surgical techniques and prevention methods to help people beat cancer in the Los Angeles area and around the world.”
For the 2020-21 rankings and ratings, U.S. News & World Report evaluated more than 4,500 medical centers nationwide in 16 specialties, 10 procedures and conditions. In the 16 specialty areas, 134 hospitals were ranked in at least one specialty.
UCLA treats some of the toughest and most challenging cancer types at Ronald Reagan UCLA Medical Center in Los Angeles and UCLA Medical Center, Santa Monica, and in many of its community clinics located throughout Southern California. UCLA specializes in providing those who have cancer and those who are affected by the disease with holistic and individualized care.
The Jonsson Comprehensive Cancer Center at UCLA is also one of only 51 cancer centers designated as “comprehensive” by the National Cancer Institute. This designation is given to cancer centers that meet the highest standards in research focused on developing new and better approaches to preventing, diagnosing and treating cancer. Cancer centers designated as comprehensive engage in community outreach activities, survivorship studies and programs, improving the quality of life for people while being treated for cancer through symptom management, studying disparities in access to healthcare services in underserved communities and providing interventions, and in training the next generation of physician-scientists, basic scientists, and population science researchers.
UCLA’s researchers develop new immunotherapies, drug-targeted therapies, CAR-T cell therapies, and cutting-edge technologies and surgical techniques. In just the last six years, researchers at UCLA have been at the forefront of cancer research studies that have resulted in more than a dozen approvals by the U.S. Food and Drug Administration. UCLA researchers also played a pivotal supporting role in the development of other FDA-approved therapies, as well as led studies that will eventually result in the next generation of cancer prevention methods, diagnostics and treatments.
UCLA researchers are dedicated to improving the quality of people’s lives. UCLA cancer research focuses on how cancer is prevented, diagnosed and managed. For cancer survivors, UCLA provides resources to those affected by cancer and its long-term effects. For underserved communities, UCLA hosts community engagement activities to raise awareness about the importance of getting screened for cancer. UCLA also studies barriers underserved communities face to access care and the interventions required to make healthcare more accessible.
UCLA Health and its Jonsson Comprehensive Cancer Center work toward the future of individualized cancer treatment that lies at the heart of how this disease forms and grows in people based on their genetic makeup. The study of health care data at the UCLA Jonsson Comprehensive Cancer Center helps physicians choose the most efficient therapies to treat an individual’s cancer.
In addition to consistently ranking on the U.S. News & World Report list, the UCLA Jonsson Comprehensive Cancer Center and its physicians and researchers have been honored with numerous prestigious awards. Among many recent honors, UCLA researchers have won three Lasker awards since 2009, including two Lasker-Debakey Clinical Medical Research Awards and the Albert Lasker Basic Medical Research Award.
“While we are deeply honored for being recognized each year as a top hospital for cancer care and research, our goal is sustained excellence and we plan to boldly blaze ahead even further so that we can better prevent, diagnose, manage, treat and eventually eliminate cancer for all peoples in all communities that we serve locally, across the nation and worldwide,” Dr. Teitell said.